These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16981678)

  • 1. Sequence and structural determinants of amyloid fibril formation.
    Bemporad F; Calloni G; Campioni S; Plakoutsi G; Taddei N; Chiti F
    Acc Chem Res; 2006 Sep; 39(9):620-7. PubMed ID: 16981678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastable, partially folded states in the productive folding and in the misfolding and amyloid aggregation of proteins.
    Ferreira ST; De Felice FG; Chapeaurouge A
    Cell Biochem Biophys; 2006; 44(3):539-48. PubMed ID: 16679542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A toy model for predicting the rate of amyloid formation from unfolded protein.
    Hall D; Hirota N; Dobson CM
    J Mol Biol; 2005 Aug; 351(1):195-205. PubMed ID: 15993421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
    Kumar S; Mohanty SK; Udgaonkar JB
    J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation.
    Esteras-Chopo A; Morra G; Moroni E; Serrano L; Lopez de la Paz M; Colombo G
    J Mol Biol; 2008 Oct; 383(1):266-80. PubMed ID: 18703072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lipid-protein interactions in amyloid-type protein fibril formation.
    Gorbenko GP; Kinnunen PK
    Chem Phys Lipids; 2006 Jun; 141(1-2):72-82. PubMed ID: 16569401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid-like fibrils.
    Yang X; Adda CG; Keizer DW; Murphy VJ; Rizkalla MM; Perugini MA; Jackson DC; Anders RF; Norton RS
    J Pept Sci; 2007 Dec; 13(12):839-48. PubMed ID: 17883245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid fibril formation and other aggregate species formed by human serum albumin association.
    Taboada P; Barbosa S; Castro E; Mosquera V
    J Phys Chem B; 2006 Oct; 110(42):20733-6. PubMed ID: 17048876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational conversion may precede or follow aggregate elongation on alternative pathways of amyloid protofibril formation.
    Kumar S; Udgaonkar JB
    J Mol Biol; 2009 Jan; 385(4):1266-76. PubMed ID: 19063899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of amyloid fibril formation--focus on domain-swapping.
    Žerovnik E; Stoka V; Mirtič A; Gunčar G; Grdadolnik J; Staniforth RA; Turk D; Turk V
    FEBS J; 2011 Jul; 278(13):2263-82. PubMed ID: 21535473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural models of amyloid-like fibrils.
    Nelson R; Eisenberg D
    Adv Protein Chem; 2006; 73():235-82. PubMed ID: 17190616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizations of distinct amyloidogenic conformations of the Abeta (1-40) and (1-42) peptides.
    Lim KH; Collver HH; Le YT; Nagchowdhuri P; Kenney JM
    Biochem Biophys Res Commun; 2007 Feb; 353(2):443-9. PubMed ID: 17184733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid fibril formation and chaperone-like activity of peptides from alphaA-crystallin.
    Tanaka N; Tanaka R; Tokuhara M; Kunugi S; Lee YF; Hamada D
    Biochemistry; 2008 Mar; 47(9):2961-7. PubMed ID: 18232642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
    Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
    J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipids enhance apolipoprotein C-II-derived amyloidogenic peptide oligomerization but inhibit fibril formation.
    Hung A; Griffin MD; Howlett GJ; Yarovsky I
    J Phys Chem B; 2009 Jul; 113(28):9447-53. PubMed ID: 19537801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation-dependent anti-amyloid oligomer antibodies.
    Kayed R; Glabe CG
    Methods Enzymol; 2006; 413():326-44. PubMed ID: 17046404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degree of structural protection at the edge beta-strands determines the pathway of amyloid formation in globular proteins.
    Soldi G; Bemporad F; Chiti F
    J Am Chem Soc; 2008 Apr; 130(13):4295-302. PubMed ID: 18335927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation.
    Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
    J Mol Biol; 2009 Oct; 392(4):1033-43. PubMed ID: 19647748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid peptides and proteins in review.
    Harrison RS; Sharpe PC; Singh Y; Fairlie DP
    Rev Physiol Biochem Pharmacol; 2007; 159():1-77. PubMed ID: 17846922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
    Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
    J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.